Ziprasidone Hydrochloride Capsule
Product Images NDC 68071-3418

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ziprasidone Hydrochloride (NDC 68071-3418). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3418 9)

The image shows a NuCare Pharmaceuticals, Inc. label for Ziprasidone 20 mg capsules, with a package size of 90 capsules. The label includes NDC 68071-3418-9 and details that each capsule contains ziprasidone hydrochloride equivalent to 20 mg of ziprasidone. The capsules are described as oblong lavender opaque caps with flesh opaque bodies, imprinted with "RDY" and "256." The label also contains barcodes, lot, expiration, and serial number placeholders, plus storage instructions and a warning to keep out of reach of children.*

FDA Label Image

Structure (Structure)

Chemical structure of ziprasidone hydrochloride showing its molecular framework including a benzisothiazole ring system, a piperazine ring, and a substituted indole moiety with chlorine and ketone functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.